CyGenica
PrivateLast Round
Seed
Jun 8, 2021
Total Funding Raised
$3.56M
Company Overview
CyGenica is a biotechnology company that provides a non-viral, non-toxic platform for safe and targeted molecular delivery for intracellular therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CyGenica Comparables
Compare CyGenica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoSyrinx | 86% | |
| Sapreme Technologies BV | 83% | |
| iDEL Therapeutics | 82% |
CyGenica Funding Rounds
Historical fundraising activity
CyGenica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Voyagers.io | Seed |
| Biotechnology Industry Research Assistance Council | Grant |
| SOSV | Convertible Debt, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors increased 2154% MoM, reaching 1.6K.
- Apr 18, 2026
Monthly visitors increased 355% MoM.
CyGenica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CyGenica's valuation, stock price, and market status.
Is CyGenica a public or private company?
CyGenica is a private company.
What is the current stock price of CyGenica?
CyGenica is a private company, so its shares have no public market price. Caplight tracks CyGenica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CyGenica worth (valuation)?
Valuation information for CyGenica is not publicly available.
Can I buy CyGenica stock?
CyGenica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CyGenica's last funding round?
CyGenica's most recent funding round was Seed on June 8, 2021.
Who are the main investors in CyGenica?
Key investors in CyGenica include SOSV.
Will CyGenica IPO soon?
No public IPO plans have been announced for CyGenica.
How can I track CyGenica secondary market activity?
Caplight tracks bids, offers, and trades in CyGenica's shares on secondary markets.